ANTIGEN AND ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, TYPE 2 AND TYPE 1 SUBGROUP O (HIV) - ANVISA Registration 10071770891

Access comprehensive regulatory information for ANTIGEN AND ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, TYPE 2 AND TYPE 1 SUBGROUP O (HIV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10071770891 and manufactured by ABBOTT DIAGNOSTICS MEDICAL CO., LTD.. The registration is held by ABBOTT DIAGNOSTICOS RAPIDOS S.A. with validity until Jun 04, 2028.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including QUIBASA QUÍMICA BÁSICA LTDA, SIEMENS HEALTHCARE DIAGNOSTICS INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10071770891
2 Related Devices
Registration Details
ANVISA Registration Number: 10071770891
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Registration Details

10071770891

25351927537201604

50248780000161

Company Information

Japan
PT: JAPÃO

Dates and Status

Jun 04, 2018

04/06/2028

09/18/2025 19:00:01

Registration Details

10071770891

25351927537201604

50248780000161

Company Information

Dates and Status

Jun 04, 2018

04/06/2028

09/18/2025 19:00:01